47 related articles for article (PubMed ID: 695486)
1. [Characteristics of distribution and elimination of DOPA-H3 and naphthidone-H3 in various forms of tumors].
Shishkina VV; Chebotareva ED; Bobrova VN; Korolev VI; Idlis SM
Vrach Delo; 1978 Jun; (6):96-100. PubMed ID: 695486
[No Abstract] [Full Text] [Related]
2. [Radiotherapeutic effect of naphthidon-3H in combined action on Harding-Passey melanoma].
Bobrova VN; Gavrilenko IS; Ivanov II; Shestakov AD
Vopr Onkol; 1975; 21(1):52-7. PubMed ID: 1119121
[No Abstract] [Full Text] [Related]
3. Uptake of radioactive DOPA by M. leprae.
Ambrose EJ; Antia NH; Khonolkar SR
Nature; 1974 Jun; 249(460):854-5. PubMed ID: 4600624
[No Abstract] [Full Text] [Related]
4. Alpha-particle track autoradiographic study of the distribution of a [211At]-astatinated drug in normal tissues of the mouse.
Mitchell JS; Brown I; Carpenter RN
Experientia; 1985 Jul; 41(7):925-8. PubMed ID: 4007129
[TBL] [Abstract][Full Text] [Related]
5. [The substitution of tritium labelled vitamin K3 under Marcumar treatment].
Ritzl F
Nucl Med (Stuttg); 1971; 9():401-4. PubMed ID: 4125938
[No Abstract] [Full Text] [Related]
6. alpha-Particle track autoradiography for localization of a 211At-astatinated drug.
Mitchell JS; Brown I; Carpenter RN
Experientia; 1983 Mar; 39(3):337-9. PubMed ID: 6825808
[TBL] [Abstract][Full Text] [Related]
7. Progress in the radiolabeling of Mycobacterium leprae.
Drutz DJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):65-71. PubMed ID: 776869
[No Abstract] [Full Text] [Related]
8. [The yet unexpected vitamin K deficiency].
Joosten P; Briët E; Veltkamp JJ
Ned Tijdschr Geneeskd; 1986 Mar; 130(11):476-9. PubMed ID: 3960150
[No Abstract] [Full Text] [Related]
9. Growth kinetics of solid tumors.
Post J; Hoffman J
Pathobiol Annu; 1972; 2():255-91. PubMed ID: 4359246
[No Abstract] [Full Text] [Related]
10. [On the metabolism of catecholamines of the adrenal gland. Light and electron microscopy radioautographic studies with 3H-Dopa on mice].
Hempel K; Kraft M
Z Zellforsch Mikrosk Anat; 1968; 85(3):322-42. PubMed ID: 5706760
[No Abstract] [Full Text] [Related]
11. Studies on the intestinal absorption of labelled fat-soluble vitamins (A, D, E, and K) via the thoracic-duct lymph in the absence of bile in man.
Forsgren L
Acta Chir Scand Suppl; 1969; 399():1-29. PubMed ID: 4311506
[No Abstract] [Full Text] [Related]
12. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.
Hare TA; Vanna S; Beasley B; Chambers R; Vogel WH
J Lab Clin Med; 1971 Feb; 77(2):319-25. PubMed ID: 5540775
[No Abstract] [Full Text] [Related]
13. Whole-body autoradiographic study of vitamin K distribution in rat.
Konishi T; Baba S; Sone H
Chem Pharm Bull (Tokyo); 1973 Jan; 21(1):220-4. PubMed ID: 4711515
[No Abstract] [Full Text] [Related]
14. [Study of the pharmacokinetics of phosphemide in rats with the use of physico-chemical methods].
Safonova TS; Presnova ZhF; Linberg LF; Chernov VA; Kuriatov NS
Farmakol Toksikol; 1975; 38(4):491-4. PubMed ID: 1213145
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the storage forms of vitamin K and dietary phylloquinone in the dog.
Duello TJ; Matschiner JT
Int J Vitam Nutr Res; 1971; 41(2):180-8. PubMed ID: 5098361
[No Abstract] [Full Text] [Related]
16. Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study.
Tjälve H
Acta Physiol Scand Suppl; 1971; 360():1-122. PubMed ID: 4933514
[No Abstract] [Full Text] [Related]
17. Synthesis of fluoro- and hydroxy-derivatives of vitamin K as substrates or inhibitors of the liver microsomal vitamin K-dependent carboxylase.
Grossman CP; Suttie JW
Biofactors; 1992 Jan; 3(3):205-9. PubMed ID: 1599614
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
[No Abstract] [Full Text] [Related]
19. [The combined action of 2,5,6-H3-DOPA and alkylating agents on Harding-Passy melanoma].
Ivanov II; Vdovenko VM; Bobrova VN; Gavrilenko IS; Rumiantseva LN
Vopr Onkol; 1972; 18(8):76-80. PubMed ID: 4657683
[No Abstract] [Full Text] [Related]
20. [Distribution and elimination of isoniazid-H3 in pulmonary tuberculosis patients].
Bondarev IM; Vasil'ev NA; Cherednichenko LP
Probl Tuberk; 1970; 48(3):65-9. PubMed ID: 5453153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
